Green Thumb Industries (GTBIF) Other Non-Current Liabilities (2019 - 2023)
Green Thumb Industries (GTBIF) posted Other Non-Current Liabilities of $33.2 million for Q4 2023, up 6.32% on a QoQ basis from $31.3 million in Q1 2023, and up 16525.0% year-over-year from N/an in Q4 2022.
Green Thumb Industries (GTBIF) Other Non-Current Liabilities (2019 - 2023) Analysis & Trends
Green Thumb Industries' Other Non-Current Liabilities history runs 5 years deep, the most recent figure standing at $33.2 million for Q4 2023.
- Quarterly Other Non-Current Liabilities rose 16525.0% year-over-year to $33.2 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $33.2 million (up 16525.0% YoY) and the FY2023 annual result came in at $33.2 million, up 16525.0% from the prior year.
- Other Non-Current Liabilities was $33.2 million for Q4 2023 at Green Thumb Industries, up from $31.3 million in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $98.5 million in Q4 2021 and bottomed at $200000.0 in Q3 2022.
- A 5-year average of $30.1 million and a median of $24.1 million in 2022 frame the typical range for Other Non-Current Liabilities.
- Annual changes were most pronounced in 2022 — Other Non-Current Liabilities tumbled 99.8% — and 2023, when it surged 16525.0%.
- Green Thumb Industries' Other Non-Current Liabilities stood at $57.0 million in 2019, then tumbled by 83.83% to $9.2 million in 2020, then surged by 968.87% to $98.5 million in 2021, then tumbled by 99.8% to $200000.0 in 2022, then jumped by 16525.0% to $33.2 million in 2023.
- Business Quant data shows GTBIF's Other Non-Current Liabilities at $33.2 million in Q4 2023, $31.3 million in Q1 2023, and $200000.0 in Q4 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Green Thumb Industries | 1.63 Bn | 1.29 Bn | 143.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 33.25 Mn |
| Mar 31, 2023 | 31.27 Mn |
| Dec 31, 2022 | 200,000.00 |
| Sep 30, 2022 | 200,000.00 |
| Jun 30, 2022 | 3.11 Mn |
| Mar 31, 2022 | 16.95 Mn |
| Dec 31, 2021 | 98.50 Mn |
| Sep 30, 2021 | 61.85 Mn |
| Jun 30, 2021 | 47.46 Mn |
| Mar 31, 2021 | 45.30 Mn |
| Sep 30, 2020 | 9.22 Mn |
| Jun 30, 2020 | 8.99 Mn |
| Mar 31, 2020 | 8.50 Mn |
| Dec 31, 2019 | 56.99 Mn |